Latest From Biotech Now

Who Cares About ALS?

ALS

1,100 days. That’s the average amount of time a person survives following a diagnosis of ALS. That is because ALS is a progressive neurodegenerative disorder defined by the loss of both upper and motor neurons which in the clinic is characterized by the atrophy of nearly all a person’s muscles.  These 1,100 days aren’t pretty. Each person will progressively lose their ability to speak, move or eat on their own. Most people will die from Read More >

Health  |  4 Comments  |  Email This Post
Tags: , , , , ,

Innovative Companies and Investment Trends in Clean Tech at World Congress

Plenary Speakers on stage 1

A recent Reuters article says the U.S. biotech sector is picking up steam in 2013 as deals are happening and attractive returns are generated. According to Reuters, “biotech IPOs have turned in a strong performance, delivering an average return of about 20 percent this year, compared with an average of 16 percent across all sectors.” This article focuses on IPOs for health biotech companies, but there is also a lot going on right now in Read More >

Biofuels & Climate Change  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Roundtable Discussion Highlights Innovation, Commercial Reality for Renewable Chemical Products

biofuels

Last week BIO brought together representatives from five renewable chemical companies that will be speaking at BIO’s World Congress on Industrial Biotechnology next month in Montreal for a roundtable discussion highlighting developments in the renewable chemical space. Bioformix, Itaconix, Newlight Technologies, Solegear and CO2 Solutions are all in the early stages of commercializing innovative renewable chemical products making it a very exciting time for the industry. “Renewable chemicals can already compete on cost with petroleum Read More >

Biofuels & Climate Change  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

Gene Patents, Angelina Jolie, and Reality

Gene Patents, Angelina Jolie, and Reality

By Dr. Hans Sauer, J.D., Deputy General Counsel for Intellectual Property, Biotechnology Industry Organization  Angelina Jolie recently announced her personal connection with breast cancer and Myriad’s BRCA genetic test.  While Jolie’s post was a commendable personal account of the real world impact of breast cancer and the real world impact of developments in healthcare technology, a few less informed individuals have tried to take advantage of this recent announcement from stardom and spread misinformation.  Let’s Read More >

Patently BIOtech  |  1 Comment  |  Email This Post
Tags: , , ,

BIO Convention Post-Con, Plus a Look Ahead

Event Signs

Last month, the biopharma community gathered for the industry’s largest event, the BIO International Convention. We hope the event was successful for everyone who attended. We know it was a busy time for folks, especially based on the numbers from the Partnering System! Here is a quick recap: BIO One-on-One Partnering Stats for BIO2013 A total of 25,537 One-on-One Partnering meetings were scheduled at the event, officially beating last year’s record! Partnering Meeting Requests increased Read More >

The One-on-One Compass  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , ,